Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D in Women With PCOS
NCT03644212Phase 4Completed
- Sponsor
- Maimonides Medical Center
- Start
- Jul 2012
- Primary completion
- Sep 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, open-label trial of vitamin d in Vitamin D deficiency (VDD) and polycystic ovary syndrome (PCOS) (2 arms), sponsored by Maimonides Medical Center. Primary endpoint: Anti-Mullerian Hormone Levels at 8 weeks. Started Jul 2012; status: completed.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT03644212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03644212.